Disease Markers

Mutations of the BRCA1 and BRCA2 Genes in Danish Patients Diagnosed at Young Age with Multi-Centric or Bilateral Breast Cancer

BRCA1 Mutation Analysis in a Portuguese Population with Early-Onset Breast and/or Ovarian Cancer

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2

Familial Cancer in Women from the Gomel Region of Belarus

Inherited Breast Cancer

Cancer Genetics Services in Europe

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

Molecular Cancer Genetics in Eastern and Central Europe

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G

Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria?

Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes

Program for Genetic Monitoring of Breast Cancer Patients and Their Families

The Czech Republic: Genetic Counseling in High-Risk Breast/Ovarian Cancer Families

Clinical Cancer Genetic Service in Sweden

Clinical Services for Familial Breast and Ovarian Cancer in Germany

Disease Markers

Table of Contents

Table of Contents: 1999

Mutations of the BRCA1 and BRCA2 Genes in Danish Patients Diagnosed at Young Age with Multi-Centric or Bilateral Breast Cancer

BRCA1 Mutation Analysis in a Portuguese Population with Early-Onset Breast and/or Ovarian Cancer

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2

Familial Cancer in Women from the Gomel Region of Belarus

Inherited Breast Cancer

Cancer Genetics Services in Europe

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

Molecular Cancer Genetics in Eastern and Central Europe

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G

Genetic Testing for Breast Cancer Predisposition in 1999: Which Molecular Strategy and which Family Criteria?

Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes

Program for Genetic Monitoring of Breast Cancer Patients and Their Families

The Czech Republic: Genetic Counseling in High-Risk Breast/Ovarian Cancer Families

Clinical Cancer Genetic Service in Sweden

Clinical Services for Familial Breast and Ovarian Cancer in Germany